Cargando…
Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophrenia
BACKGROUND: Heterogeneity among patients’ responses to treatment is prevalent in psychiatric disorders. Personalized medicine approaches—which involve parsing patients into subgroups better indicated for a particular treatment—could therefore improve patient outcomes and serve as a powerful tool in...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135147/ https://www.ncbi.nlm.nih.gov/pubmed/34016112 http://dx.doi.org/10.1186/s12911-021-01510-0 |